REDWOOD CITY, Calif. (AP) _ Genomic Health Inc. (GHDX) on Wednesday reported fourth-quarter net income of $8.9 million.
On a per-share basis, the Redwood City, California-based company said it had profit of 23 cents. Earnings, adjusted for non-recurring costs, came to 32 cents per share.
The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 30 cents per share.
The cancer test maker posted revenue of $104.6 million in the period, also beating Street forecasts. Seven analysts surveyed by Zacks expected $101.8 million.
For the year, the company reported net income of $25.7 million, or 68 cents per share, swinging to a profit in the period. Revenue was reported as $394.1 million.
Genomic Health expects full-year earnings in the range of $1.38 to $1.54 per share, with revenue in the range of $436 million to $448 million.
Genomic Health shares have climbed 30 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $83.66, more than doubling in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GHDX at https://www.zacks.com/ap/GHDX